Zobrazeno 1 - 5
of 5
pro vyhledávání: '"D. Chakieva"'
Autor:
Alexander Lila, I. M. Marusenko, I. Grabovetskaya, A. Baranov, E. Gaydukova, Nasonov El, V. Sorotskaya, V. Mazurov, T. Salnikova, Galina Lukina, D. Chakieva, Inna Gaydukova, A. R. Babaeva, E. Kalinina, R. Samigullina
Publikováno v:
Annals of the Rheumatic Diseases. 79:1469-1470
Background:Tofacitinib is an oral Janus Kinase inhibitor for the treatment of rheumatoid arthritis (RA). The survival of remission or low disease activity (LDA) in RA patients, treated with tofacitinib remain unknown.Objectives:To evaluate the surviv
Autor:
R. Samigullina, N. Kiryukhina, T. Salnikova, T. Rasevich, Nasonov El, E. Kalinina, I. Semizarova, I. Bashkova, D. Kretchikova, D. Bobrikova, I. Vinogradova, V. Sorotskaya, E. Koltsova, A. Dyo, I. Shchendrigin, O. Semagina, A. Dadalova, M. Semchenkova, D. Murtazalieva, Alexander Lila, V. Mazurov, D. Chakieva, A. Davydova, I. Shafieva, A. Baranov, N. Lapkina, I. M. Marusenko, I. Kushnir, A. Karateev
Publikováno v:
Annals of the Rheumatic Diseases. 80:1095.3-1096
Background:JAK inhibitors block intracellular signaling pathways responsible for the synthesis of cytokines and mediators involved in the development of chronic pain and central sensitization (CS). This determines a very rapid clinical response to JA
Autor:
Alexander Lila, D. Chakieva, V. Mazurov, A. Karateev, V N Amirdzhanova, O. Semagina, I. M. Marusenko, T. Salnikova, M. Semchenkova, Nasonov El, E. Pogozheva, E. Filatova, N. Lapkina, Galina Lukina, R. Samigullina
Publikováno v:
Annals of the Rheumatic Diseases. 79:327.3-327
Background:The presence of central sensitization (CS) significantly burdens the course of rheumatoid arthritis (RA). JAK inhibitors block intracellular signal pathways including the ones responsible for synthesis of mediators and cytokines causing pa
Autor:
E. L. Luchikhina, N. Chichasova, G. Gafurova, D. Chakieva, L. Bogoderova, R. Mukhina, Diana Abdulganieva, R. Samigullin, D.E. Karateev, M. Bilinskaya, N. Lapkina, A. Satybaldyev, M. Nikolenko, M. Dmitrieva, Galina Lukina, V. Sorotskaya, E. Nassonov, Mazurov Vi
Publikováno v:
Annals of the Rheumatic Diseases. 75:1002.2-1002
Background Russian register of patients with inflammatory arthritis started in 2012 as a register of RA (“All-Russian register of Rheumatoid Artritis”- ARRA) now transformed into “Observational REgister of arthritis in cLinical practice” (ORE
Autor:
N. Lapkina, Mazurov Vi, A Misiyuk, A. Baranov, E. L. Luchikhina, O. Semagina, E. Kalinina, D. Chakieva, D. Petrov, A. R. Babaeva, Nasonov El, Diana Abdulganieva, A. Sizikov, R. Samigullina, S A Lapshina, T. Salnikova, O. Chumasova, O. Ivanova, V. Sorotskaya, N. Demidova, D.E. Karateev
Publikováno v:
Annals of the Rheumatic Diseases. 75:1036.2-1036
Background Tofacitinib (TOFA) was approved in Russia for treatment of patients with rheumatoid arthritis (RA) in 2013, but published information about its post-approval use limited to some individual clinical observations. Objectives To study the eff